Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014

ELRIG - Drug Discovery 2014

02 Sep 2014 - 03 Sep 2014 - Manchester, UK

Bookmark and Share

The scientific sessions will include Innovations in Assay Development, Oncology Drug Discovery, Target Validation and Engineered Proteins for Therapy.

We are delighted to introduce three new science sessions this year, which will cover cutting-edge thinking in several therapeutic and discovery opportunities and techniques - Phenotypic Discovery & Cellular Imaging, Neuroscience Drug Targets, and Chemistry Innovation in Lead Discovery.

Another exciting addition to our conference this year is a series of Core Technologies Workshops. These will provide a more informal, interactive environment for you to discuss key issues and future directions in Innovative Automation, Complex Data, Sample Management, and Safety & Metabolism Screening, in workshops coordinated by leaders in the fields.

ELRIG Drug Discovery 2014 will include a high quality scientific poster session, networking opportunities, and an extensive vendor exhibition.

Each year, the ELRIG Drug Discovery conference provides a fantastic communication and learning opportunity for scientists engaged in research fields across drug discovery, bringing together  Academia, Biotech, Vendors, & Pharma, into a single community of scientists. It is now well established as the leading annual drug discovery event held in the UK.

Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos